tiprankstipranks
E-Therapeutics PLC (GB:ETX)
LSE:ETX

E Therapeutics (ETX) Cash flow

5 Followers

E Therapeutics Cash Flow

GB:ETX's free cash flow for Q2 2022 was £―. For the 2022 fiscal year, GB:ETX's free cash flow was decreased by £541.00K and operating cash flow was £―. See a summary of the company’s cash flow.
Cash Flow
TTM
Jan 23Jan 22Jan 21Jan 20Jan 19
Operating Cash Flow
-£ -8.01M£ -7.80M£ -3.36M£ -2.03M£ -3.70M
Investing Cash Flow
-£ 15.31M£ -9.94M£ -5.07M£ -1.00K£ 2.50M
Financing Cash Flow
-£ 13.05M£ 22.33M£ 12.60M£ -35.00K£ 11.00K
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
-£ 31.94M£ 11.60M£ 7.00M£ 3.84M£ 5.90M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
-£ 13.44M£ 21.67M£ 12.64M£ 11.00K£ 11.00K
Issuance Of Debt
-£ -391.00K£ 663.00K---
Repayment Of Debt
-£ -391.00K£ -130.00K---
Free Cash Flow
-£ -8.22M£ -8.76M£ -3.43M£ -2.04M£ -3.73M
Domestic Sales
------
Foreign Sales
------
Currency in GBP

E Therapeutics Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis